ArticleMethods in molecular biology (Clifton, N.J.)2026
Comprehensive Assessment of Neutrophil Function in Autoimmune Diseases.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neutrophils play a crucial role in autoimmune diseases beyond their well-characterized effector functions like phagocytosis and NETosis. Comprehensive assessment of neutrophil function is essential for understanding their diverse contributions to autoimmunity, including their roles in cytokine production and reactive oxygen species (ROS) generation. This chapter provides detailed methodologies for evaluating neutrophil immunomodulatory functions relevant to autoimmune pathology. We describe assays for quantifying cytokine and chemokine profiling by multiplex approaches and ROS production using flow cytometry. These methods enable researchers to dissect the nuanced contributions of neutrophils to autoimmune diseases, facilitating the identification of novel therapeutic targets.
Indexed as
Identifiers
41269550What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.